Endogenous angiotensin II suppresses insulin signaling in vascular smooth muscle cells from spontaneously hypertensive rats

Journal of Hypertension

Volumn 19, Issue 9, 2001, Pages 1651-1658

  Fukuda, Noboru ^a   Satoh, Chikara ^a   Hu, Wen Yang ^a   Nakayama, Mari ^a   Kishioka, Hirobumi ^a   Kanmatsuse, Katsuo ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Hypertension; Insulin resistance; Mitogen activated protein kinase; Vascular smooth muscle

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; OLMESARTAN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P85; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DOSE RESPONSE; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

EID: 0034864881     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200109000-00018     Document Type: Article

References (20)

1. The insulin signaling system
2. Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat
3. The mechanisms of the improvement of insulin sensitivity by angiotensin converting enzyme inhibitor
4. Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension
5. Cross-talk between the insulin and angiotensin signaling systems
6. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk
7. Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats
8. Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats
9. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers
10. Analytical luminescence: Its potential in the clinical laboratory
11. Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells
12. Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase
13. Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension
14. Glucose intolerance in spontaneously hypertensive and Wistar-Kyoto rats: Enhanced gene expression and synthesis of skeletal muscle glucose transporter 4
15. Extracellular signal-regulated kinase and c-Jun NH2-terminal kinase activities are continuously and differentially increased in aorta of hypertensive rats
16. Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery
17. Role of endogenous angiotensin II in the increased expression of growth factors in vascular smooth muscle cells from sponteneously hypertensive rats
18. Endogenous angiotensin II regulates the cell cycle of vascular smooth muscle cells from spontaneously hypertensive rats
19. Insulin resistance and hypertension
20. Losartan: First of a new class of angiotensin antagonists for the management of hypertension